Quality is not just promised — it's proven. Every batch comes with a full COA and detailed in-house test reports (HPLC, ¹H NMR, MS). We also routinely send samples to accredited third-party labs and publish their results without delay.
⚠ LEGAL DISCLAIMER: This product is an Active Pharmaceutical Ingredient (API) intended for research, laboratory development, and commercial manufacturing purposes. AASchem supplies raw materials to manufacturers and certified laboratories. We do not provide medical advice or dosage recommendations for end-user consumption.
⚠ LEGAL DISCLAIMER: This product is an Active Pharmaceutical Ingredient (API) intended for research, laboratory development, and commercial manufacturing purposes. AASchem supplies raw materials to manufacturers and certified laboratories. We do not provide medical advice or dosage recommendations for end-user consumption.
For the usage and dosage of ACE-031, please refer to the professional guidance provided by the original pharmaceutical company. As a professional manufacturer of ACE-031, AASchem respects and appreciates the research contributions of the original pharmaceutical company and does not provide product usage recommendations.
Some people may loosely call ACE-031 a "peptide", but strictly ACE-031 is actually a fusion protein — specifically, a soluble form of the activin receptor type IIB (ActRIIB) fused to the Fc region of human IgG1. It is designed to act as a "ligand trap" that binds and neutralizes myostatin and other TGF-β family proteins that inhibit muscle growth.
ACE-031 works by binding to myostatin and related proteins before they can interact with their cell surface receptors. By blocking this signaling pathway, ACE-031 effectively removes the body's natural "brake" on muscle fiber development, allowing for significant increases in lean muscle mass even without exercise stimulus.
In the pharmaceutical manufacturing context, ACE-031 is used as:
Reference Standard: For analytical method development in bioanalytical laboratories.
Process Research: Studying protein folding, stability, and formulation optimization.
Preclinical Studies: In vitro and in vivo efficacy studies for muscular dystrophy drug development programs.
